Shanghai Bao Pharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 19.88 average price

PUBT · 2d ago
Shanghai Bao Pharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 19.88 average price
  • Shanghai Bao Pharmaceuticals repurchased 100,300 H shares on July 15, 2026 for treasury; no shares were repurchased for cancellation.
  • Buyback executed on HKEX at HKD 19.43 to HKD 20.12 per share; aggregate consideration HKD 1,993,855.
  • Issued shares excluding treasury fell to 153,291,250; treasury shares rose to 1,036,000.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12245182), on July 15, 2026, and is solely responsible for the information contained therein.